Recent studies have established that HBV PreS deletion is positively associated with liver fibrosis progression in chronic HBV-infected patients, with preS2 deletions serving as warning indicators for liver fibrosis progression [8,18,19]. Here, SLC26A5 is linked to Hepatic fibrosis.